Found 0 matching trials
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma PHASE2 This phase II trial studies the effect of belinostat and SGI-110 (guadecita...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Learn More & Join Trial
Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome PHASE1 The purpose of this study is to determine the pharmacokinetics (PK) of deci...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases PHASE1 This phase I trial is studying the side effects and best dose of vorinostat...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction PHASE3 To compare efficacy and safety between SGI-110 and Treatment Choice in adul...
Show More Location
Mayo Clinic Cancer Center
Learn More & Join Trial
Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS) PHASE3 This is a prospective,controlled and multi-institution trial.The aim is to ...
Show More Location
Ruijin Hospital North
Learn More & Join Trial
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML PHASE2 The primary objectives of this study are to assess: (1) whether the combina...
Show More Location
UCLA Medical Center
Learn More & Join Trial
ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase PHASE2 This phase II trial studies the effect of ASTX727 and dasatinib in treating...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60 PHASE1 STUDY BACKGROUND AND PURPOSE:
Acute myelogenous leukemia (AML) is a common...
Show More Location
Winship Cancer Institute of Emory University
Learn More & Join Trial
Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial PHASE4 This study aims to determine whether the recurrence rate of high-risk acute...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Decitabine in Treating Patients With Myelodysplastic Syndrome PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Johns Hopkins Oncology Center
Learn More & Join Trial